EQRx Seeks To Establish A More Competitive Market For Oncology Drugs In The U.S. EQRx aims to bring new medicines to market at what it states will be “radically lower” prices. The company is hoping to disrupt the cancer immunotherapy market and take on blockbuster drugs, such as Keytruda.